The novel Bruton's tyrosine kinase inhibitor ARQ531 disrupts survival signaling and triggers apoptosis in AML cells

被引：0
|
作者：
Debora, Soncini [1 ]
Orecchioni, Stefania [2 ]
Cagnetta, Antonia [1 ]
Retali, Veronica [1 ]
Ruberti, Samantha [1 ]
Minetto, Paola [1 ]
Contini, Paola [1 ]
Nencioni, Alessio [1 ]
Monacelli, Fiammetta [1 ]
Hall, Terence [3 ]
Gobbi, Marco [1 ]
Eathiraj, Sudharshan [3 ]
Schwartz, Briam [3 ]
Bertolini, Francesco [2 ]
Lemoli, Roberto [1 ]
Cea, Michele [1 ]
机构：
[1] Univ Genoa, Genoa, Italy
[2] European Inst Oncol, Milan, Italy
[3] ARQULE, Burlington, MA USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-793
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
793
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A novel small molecule FAK tyrosine kinase inhibitor increases apoptosis in pancreatic adenocarcinoma cells
    Bloom, DA
    Cance, WG
    Ohmori, O
    Hatakeyama, S
    Honda, T
    Kurenova, E
    Golubovskaya, V
    Hochwald, S
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 4 - 4
  • [32] A Novel Role for Bruton's Tyrosine Kinase in Hepatocyte Growth Factor-mediated Immunoregulation of Dendritic Cells
    Singhal, Eshu
    Kumar, Prakash
    Sen, Pradip
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (37) : 32054 - 32063
  • [33] AMPLIFICATION OF IL-21 SIGNALING PATHWAY THROUGH BRUTON'S TYROSINE KINASE (BTK) IN HUMAN B CELLS
    Wang, S. -P.
    Iwata, S.
    Yamaoka, K.
    Niiro, H.
    Nakayamada, S.
    Tabrizi, S. J.
    Kubo, S.
    Kondo, M.
    Akashi, K.
    Tanaka, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 119 - 120
  • [34] Significant Species Difference in Amide Hydrolysis of GDC-0834, a Novel Potent and Selective Bruton's Tyrosine Kinase Inhibitor
    Liu, Lichuan
    Halladay, Jason S.
    Shin, Young
    Wong, Susan
    Coraggio, Melis
    La, Hank
    Baumgardner, Matthew
    Le, Hoa
    Gopaul, Sashi
    Boggs, Jason
    Kuebler, Peter
    Davis, John C., Jr.
    Liao, X. Charlene
    Lubach, Joseph W.
    Deese, Alan
    Sowell, C. Gregory
    Currie, Kevin S.
    Young, Wendy B.
    Khojasteh, S. Cyrus
    Hop, Cornelis E. C. A.
    Wong, Harvey
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (10) : 1840 - 1849
  • [35] TAS5315, a Novel Bruton's Tyrosine Kinase Inhibitor, Improves Bone Strength in Mouse Model for Rheumatoid Arthritis
    Kaneko, Ryuusuke
    Hosoi, Fumihito
    Iguchi, Satoru
    Hayashi, Hiroaki
    Yoshiga, Yohei
    Nakachi, Yoshinori
    Akasaka, Daichi
    Tanaka, Kenji
    Utsugi, Teruhiro
    Sasaki, Eiji
    Iwasawa, Yoshikazu
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [36] Significant Species Difference of Amide Hydrolysis of GDC-0834, a Novel Potent and Selective Bruton's Tyrosine Kinase Inhibitor
    Liu, Lichuan
    Halladay, Jason
    Shin, Young
    Wong, Susan
    Coraggio, Melis
    La, Hank
    Baumgardner, Matthew
    Le, Hoa
    Kuebler, Peter
    Davis, John C., Jr.
    Liao, X. Charlene
    Lubach, Joseph
    Deese, Alan
    Sowell, C. Gregory
    Currie, Kevin S.
    Young, Wendy B.
    Khojasteh, Cyrus
    Hop, Cornelis
    Wong, Harvey
    DRUG METABOLISM REVIEWS, 2010, 42 : 235 - 235
  • [37] ONO-4059-A Novel Small Molecule Bruton's Tyrosine Kinase (Btk) Inhibitor, Suppresses Osteoclast Differentiation and Activation
    Ariza, Yuko
    Yoshizawa, Toshio
    Ueda, Yoshiko
    Hotta, Shingo
    Narita, Masami
    Kawabata, Kazuhito
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S766 - S767
  • [38] AML CELLS SENSITIVE TO THE NOVEL TYROSINE KINASE INHIBITOR AKN-028 SHOW A HIGHER OVERALL TYROSINE KINASE ACTIVITY THAN MORE RESISTANT SAMPLES
    Eriksson, A.
    Jarvius, M.
    Hilhorst, R.
    de Wijn, R.
    Hovestad, L.
    Fryknas, M.
    Larsson, R.
    Parrow, V.
    Hoglund, M.
    HAEMATOLOGICA, 2013, 98 : 511 - 511
  • [39] ONO-WG-307, a novel, potent and selective inhibitor of Bruton's tyrosine kinase (Btk), results in sustained inhibition of the ERK, AKT and PKD signaling pathways
    Yasuhiro, Tomoko
    Yoshizawa, Toshio
    Daub, Henrik
    Weber, Christoph
    Narita, Masami
    Kawabata, Kazuhito
    CANCER RESEARCH, 2012, 72
  • [40] A phase I trial of PRN1008, a novel reversible covalent inhibitor of Bruton's tyrosine kinase, in healthy volunteers
    Smith, Patrick F.
    Krishnarajah, Janakan
    Nunn, Philip A.
    Hill, Ron J.
    Karr, Dane
    Tam, D.
    Masjedizadeh, Mohammad
    Funk, Jens O.
    Gourlay, Steve G.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (11) : 2367 - 2376
12345